Andrew J. Krentz,
Robert J. Chilton
Elsevier Science
e druk, 2023
9780323999915
Cardiovascular Endocrinology and Metabolism
Theory and Practice of Cardiometabolic Medicine
Specificaties
Paperback, blz.
|
Engels
Elsevier Science |
e druk, 2023
ISBN13: 9780323999915
Rubricering
Levertijd ongeveer 8 werkdagen
Samenvatting
Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic Medicine discusses the close intersection between metabolic disorders and cardiovascular disease, covering the basic science and pathophysiology of disease and the latest research in pharmacological approaches and translational therapeutic options. This book is a valuable resource for the vascular and endocrinology clinical and research communities in need of knowledge and potential outcomes.
The global increase in the prevalence of cardiometabolic disorders, and the introduction of therapeutic options for treating metabolic disease that also lower cardiovascular risk, is bringing endocrinologists and cardiologists together in a shared clinical experience.
Specificaties
Inhoudsopgave
Part 1. Basic science and pathophysiology<br>1. Obesity and insulin resistance<br>2. Diabetes and macrovascular disease: epidemiology and cardiovascular risk assessment<br>3. Hypertension<br>4. Lipid metabolism: role in atherogenesis<br>5. Renal disease and cardiorenal interactions<br>6. NAFLD/NASH and cardiovascular risk<br>7. Heart failure<br>8. Prothrombosis: association with cardiometabolic disease<br>9. Inflammation, metabolism and cardiovascular disease<br>10. Classic endocrine disorders: association with vascular disease<br><br>Part 2. Clinical evaluation, lifestyle measures and therapeutic options<br>11. Non-pharmacological strategies in the prevention and management of cardiometabolic disease<br>12. Obesity: pharmacological approaches to prevention and management<br>13. Diabetes: evolution of multifactorial vascular risk reduction<br>14. Diabetes CVOTS: design, interpretation and future directions<br>15. Novel glucose-lowering drugs: a new era of cardioprotection and renoprotection<br>16: Hypertension: pharmacological and surgical management<br>17. PCSK-9 inhibitors and other novel lipid-modifying drugs<br>18. Recent therapeutic developments in heart failure<br>19. Antiplatelet agents<br>20. Progress in anticoagulant therapy<br>21. Invasive treatment of atherosclerotic cardiovascular disease: today and tomorrow<br>22. Cardiometabolic medicine in practice: role of cardiologists vs endocrinologists and the need for a new clinical specialty